BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12222560)

  • 21. Pneumatosis intestinalis after etoposide-based chemotherapy in a patient with metastatic small cell lung cancer: successful conservative management of a rare condition.
    Faria LD; Anjos CH; Fernandes GD; Carvalho IF
    Einstein (Sao Paulo); 2016; 14(3):420-422. PubMed ID: 27532522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group.
    Nakanishi Y; Kawarada Y; Hirose N; Ninomiya K; Miyazaki M; Miyazaki N; Kurita Y; Kanegae H; Ohgushi O; Ogata K; Yamazaki H; Inutsuka S; Hara N
    Cancer Chemother Pharmacol; 1998; 41(6):453-6. PubMed ID: 9554588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Bilateral Renal and Splenic Infarctions Occurring during Chemotherapy for Lung Cancer.
    Koyama N; Tomoda K; Matsuda M; Fujita Y; Yamamoto Y; Hontsu S; Tasaki M; Yoshikawa M; Kimura H
    Intern Med; 2016; 55(24):3635-3639. PubMed ID: 27980265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
    Perez-Soler R; Glisson BS; Lee JS; Fossella FV; Murphy WK; Shin DM; Hong WK
    J Clin Oncol; 1996 Oct; 14(10):2785-90. PubMed ID: 8874340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial thrombosis in a patient after chemotherapy (BEP protocol) for extra-gonadal dysgerminoma].
    Schmidt J; Zenut M; De Marquilly F; Maciejewski C; Plagne R; Lavarenne J
    Therapie; 1995; 50(5):476-8. PubMed ID: 8571294
    [No Abstract]   [Full Text] [Related]  

  • 26. Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer.
    Mathews J; Goel R; Evans WK; Shamji F; Stewart DJ
    Cancer Chemother Pharmacol; 1997; 40(1):19-22. PubMed ID: 9137524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.
    Helsing M; Bergman B; Thaning L; Hero U
    Eur J Cancer; 1998 Jun; 34(7):1036-44. PubMed ID: 9849452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
    J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer].
    You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
    Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):55-60. PubMed ID: 28103974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
    Mellema WW; van der Hoek D; Postmus PE; Smit EF
    Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
    Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab-induced Aortic Arterial Thrombosis.
    Suzuki K; Yanagimura T; Ohashi K; Kagamu H; Takada T
    Intern Med; 2018 Oct; 57(20):2987-2990. PubMed ID: 29780110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of ovarian endodermal sinus tumor diagnosed during pregnancy.
    Thanaboonyawat I; Benjapibal M
    J Med Assoc Thai; 2008 May; 91(5):764-8. PubMed ID: 18672645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of acute aortic thrombosis after cisplatin-based chemotherapy.
    Hahn SJ; Oh JY; Kim JS; Kim DY
    Int J Clin Oncol; 2011 Dec; 16(6):732-6. PubMed ID: 21455627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged administration of infusional cisplatin and oral etoposide in advanced non-small cell lung cancer.
    Jazieh AR; Kyasa MJ; Muirhead MJ
    Anticancer Drugs; 2002 Sep; 13(8):815-8. PubMed ID: 12394265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer.
    van Zuylen L; Schellens JH; Goey SH; Pronk LC; de Boer-Dennert MM; Loos WJ; Ma J; Stoter G; Verweij J
    Anticancer Drugs; 1999 Apr; 10(4):361-8. PubMed ID: 10378670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
    Langer CJ; Manola J; Bernardo P; Kugler JW; Bonomi P; Cella D; Johnson DH
    J Natl Cancer Inst; 2002 Feb; 94(3):173-81. PubMed ID: 11830607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
    Rapp JS; Perry MC; Rotche RM
    Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemically-induced paraneoplastic hyperleukocytic lung].
    Le Guen Y; Lebeau B
    Rev Mal Respir; 1999 Dec; 16(6):1139-41. PubMed ID: 10637912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.